Skip Navigation


JAC Advance Access originally published online on October 7, 2004
Journal of Antimicrobial Chemotherapy 2004 54(5):881-888; doi:10.1093/jac/dkh440
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
54/5/881    most recent
dkh440v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Decré, D.
Right arrow Articles by Arlet, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Decré, D.
Right arrow Articles by Arlet, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

JAC vol.54 no.5 © The British Society for Antimicrobial Chemotherapy 2004; all rights reserved

Outbreak of multi-resistant Klebsiella oxytoca involving strains with extended-spectrum ß-lactamases and strains with extended-spectrum activity of the chromosomal ß-lactamase

Dominique Decré1,2,*, Béatrice Burghoffer1, Valérie Gautier1, Jean-Claude Petit1,2 and Guillaume Arlet1,3

1 UPRES n°EA2392, Faculté de Médecine, UFR Saint-Antoine, Université Paris 6; 2 Laboratoire de bactériologie, Hôpital Saint Antoine, 27 rue Chaligny, 75012 Paris Cedex 12; 3 Laboratoire de bactériologie Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, France

* Corresponding author. Tel: +33-1-40-01-13-82; Email: dominique.decre{at}chusa.jussieu.fr

Objectives: This study was conducted to analyse broad-spectrum cephalosporin-resistant Klebsiella oxytoca strains.

Methods: The 57 isolates studied were recovered from clinical specimens (n=23) or from rectal swabs (n=34) during a 26-month period. Antibiotic susceptibility patterns were determined using standard agar diffusion and dilution methods including the synergy test between extended-spectrum cephalosporins and clavulanic acid. ERIC-2 PCR and pulsed-field gel electrophoresis (PFGE) methods were used to study the clonal relatedness of the strains. Plasmid-mediated and chromosomal ß-lactamases were characterized by mating and specific bla gene amplification and sequencing.

Results: Four different antibiotic resistance patterns were identified whereas ERIC-2 PCR and PFGE revealed six main profiles. Extended-spectrum ß-lactamases (ESBLs) were found in 32 strains: TEM-7 (n=26), TEM-129 (n=1), TEM-3 (n=4), SHV-2 (n=1). The new TEM-type ß-lactamase, TEM-129, differed from TEM-7 by one mutation (Glu-104->Lys). All TEM-7 or TEM-129 producers were genetically related. Twenty-five other strains with identical ERIC-2 PCR and PFGE profiles harboured a blaOXY-2 gene different from the reference gene: 24 strains displayed one substitution (Ala-237->Ser) in the KTG motif and one strain, highly resistant to ceftazidime, showed an additional substitution (Pro-167->Ser).

Conclusions: The study demonstrated that the majority of strains (n=52) harbouring the OXY-2-type ß-lactamase corresponded to two clones. The first clone (n=27) corresponded to ESBL-producing strains. The second clone (n=25) displayed extended-spectrum activity of the chromosomal ß-lactamase.

Keywords: OXY-2 ß-lactamase , TEM-7 , TEM-129


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
M. Barlow, J. Fatollahi, and M. Salverda
Evidence for recombination among the alleles encoding TEM and SHV {beta}-lactamases
J. Antimicrob. Chemother., February 1, 2009; 63(2): 256 - 259.
[Abstract] [Full Text] [PDF]

Home page
 J Med MicrobiolHome page
Y. Zhang, H. Zhou, X.-q. Shen, P. Shen, Y.-s. Yu, and L.-j. Li
Plasmid-borne armA methylase gene, together with blaCTX-M-15 and blaTEM-1, in a Klebsiella oxytoca isolate from China
J. Med. Microbiol., October 1, 2008; 57(10): 1273 - 1276.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
J. E. Mroczkowska and M. Barlow
Recombination and Selection Can Remove blaTEM Alleles from Bacterial Populations
Antimicrob. Agents Chemother., September 1, 2008; 52(9): 3408 - 3410.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
H. Iabadene, Y. Messai, H. Ammari, N. Ramdani-Bouguessa, S. Lounes, R. Bakour, and G. Arlet
Dissemination of ESBL and Qnr determinants in Enterobacter cloacae in Algeria
J. Antimicrob. Chemother., July 1, 2008; 62(1): 133 - 136.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
J. E. Mroczkowska and M. Barlow
Fitness Trade-Offs in blaTEM Evolution
Antimicrob. Agents Chemother., July 1, 2008; 52(7): 2340 - 2345.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
M. S. Zarate, A. C. Gales, R. C. Picao, G. S. Pujol, A. Lanza, and J. Smayevsky
Outbreak of OXY-2-Producing Klebsiella oxytoca in a Renal Transplant Unit
J. Clin. Microbiol., June 1, 2008; 46(6): 2099 - 2101.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
N. Kassis-Chikhani, D. Decre, V. Gautier, B. Burghoffer, F. Saliba, D. Mathieu, D. Samuel, D. Castaing, J.-C. Petit, E. Dussaix, et al.
First outbreak of multidrug-resistant Klebsiella pneumoniae carrying blaVIM-1 and blaSHV-5 in a French university hospital
J. Antimicrob. Chemother., January 1, 2006; 57(1): 142 - 145.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
D. L. Paterson, F. Rossi, F. Baquero, P.-R. Hsueh, G. L. Woods, V. Satishchandran, T. A. Snyder, C. M. Harvey, H. Teppler, M. J. DiNubile, et al.
In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART)
J. Antimicrob. Chemother., June 1, 2005; 55(6): 965 - 973.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.